
By the time Ernest's esophageal cancer was discovered, he was at stage 4. He was quite sick and was losing weight and strength. The standard treatment available at this time only extends life for months; long-term survival rates are grim.
He almost refused any treatment (because of the horror stories about chemotherapy) until we went to MD Anderson last August for a consultation. When the doctor explained the clinical trial for immunotherapy, I saw my husband's eyes light up with hope for the first time since his diagnosis. He decided he would join the clinical trial as his best hope for survival and to assist with the approval of the drug for other patients.
<